Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol for stress and inflammatory response during partial laryngectomy
ChiCTR2400092127Phase 4Recruiting
- Sponsor
- Tengzhou Central People's Hospital
- Start
- Nov 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esmolol in laryngeal cancer (2 arms), sponsored by Tengzhou Central People's Hospital. Primary endpoints: Blood pressure and heart rate values, Interleukin-1β and 5 more. Started Nov 2024; status: recruiting.
02
Drugs
esmolol
03
Conditions
laryngeal cancer
Beyond the preview
Go deeper on ChiCTR2400092127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092127.